Clinical TrialsSearch results
Number of results: 521
Other
- Romdomized study to evaluate the renoprotective effects of clarithromycin for diabetic patients with microalbuminuria.
- Diabetic nephropathy
- Okayama university graduate school of medicine, dentistry and pharmaceutical sciences, Department of medicine and clinical science
- 2005-12-30
Other
- Gefitnib monotherapy in patients with post-operative recurrent non-small-cell lung cancer with the EGFR mutation: a Phase II study
- non small cell lung cancer with EGFR mutation
- Okayama University Cancer and Thoracic Surgery
- 2006-04-24
Other
- Randomized comparative study of cisplatin, docetaxel, and irinotecan versus cisplatin and docetaxel in patients with stage IIIB or stage IV non-small cell lung cancer (OLCSG 0403)
- Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Okayama Lung Cancer Study Group (OLCSG)
- 2005-09-13
Other
- Randomized, comparative clinical study of cisplatin and docetaxel combination chemotherapy and mitomycin, vindesine and cisplatin (MVP) combination chemotherapy with concurrent thoracic radiation therapy for locally advanced unresectable non-small-cell lung cancer (OLCSG0007)
- inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group (OLCSG)
- 2005-09-12
Other
- Phase I study of S-1 with concurrent thoracic radiation therapy for elderly inoperable locally advanced non-small-cell lung cancer
- Elderly inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase I/II study of cisplatin and S-1 with concurrent thoracic radiation therapy for inoperable locally advanced non-small-cell lung cancer (OLCSG 0501)
- inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of cisplatin, docetaxel, and irinotecan, followed by gefitinib, gemcitabine and vinorelbine for patients with non-small-cell lung cancer harboring active EGFR gene mutations (OLCSG0704)
- non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2009-08-01
Other
- Phase II study of erlotinib monotherapy for relapsed patients with non-small-cell lung cancer who do not possess any active EGFR gene mutations
- relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2008-11-16
Other
- Phase II study of irinotecan and amrubicin for relapsed non-small-cell lung cancer
- Relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of topotecan and amrubicin for metastatic or relapsed small-cell lung cancer
- Metastatic or relapsed small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12